Join to View Full Profile
1600 Republic PkwySte 200Mesquite, TX 75150
Phone+1 972-288-2600
Dr. Singhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Rheumatology, 1992 - 1995
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1989 - 1992
All India Institute of Medical SciencesClass of 1987
Certifications & Licensure
TX State Medical License 1995 - 2026
NJ State Medical License 1994 - 1997
PA State Medical License 1992 - 1996
American Board of Internal Medicine Rheumatology
Clinical Trials
- Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) Start of enrollment: 2020 Jul 01
Roles: Contact
- Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2021 Jan 11
- A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) Start of enrollment: 2021 Oct 11
Publications & Presentations
PubMed
- 2 citationsUpadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized cont...Ronald van Vollenhoven, Vibeke Strand, Tsutomu Takeuchi, Nilmo Chávez, Pablo Mannucci Walter
Arthritis Research & Therapy. 2024-07-29 - 3 citationsEfficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies.Alan J Kivitz, Joel M Kremer, Clarence W Legerton 3rd, Luminita Pricop, Atul Singhal
Rheumatology and Therapy. 2024-06-01 - 217 citationsSecukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 s...Philip J. Mease, Désirée van der Heijde, Robert Landewé, Shephard Mpofu, Proton Rahman
Annals of the Rheumatic Diseases. 2018-03-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
